COMMUNIQUÉS West-GlobeNewswire

The American Health Council Appoints Theresa Gutierrez, MSN, RN, FNP to Nursing Board
02/02/2018
NEW YORK, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Theresa Gutierrez, MSN, RN, FNP, has been appointed to the American Health Council’s Nursing Board. Ms. Gutierrez brings an abundance of experience from spending 21 years [...]
PetVivo Holdings, Inc. Approaches Commercial Production
02/02/2018
MINNEAPOLIS, Feb. 02, 2018 (GLOBE NEWSWIRE) -- A long-awaited day is approaching for PetVivo Holdings, Inc. ( www.petvivo.com ) (OTCMARKETS:PETV), an emerging biomedical device company. We are speaking of commercial [...]
Delcath Announces 500th Commercial CHEMOSAT Treatment in Europe
02/02/2018
NEW YORK, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that physicians in Europe [...]
Extendicare Announces Timing of 2017 Fourth Quarter and Year End Results and Conference Call
02/02/2018
MARKHAM, Ontario, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) announced today that it plans to release its financial results for the fourth quarter and year ended [...]
Kamada to Announce Fiscal Year 2017 Financial Results and Host Conference Call on February 7
02/02/2018
REHOVOT, Israel, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA ) (TASE: KMDA ), a plasma-derived protein therapeutics company focused on orphan indications, today announced that it will release financial [...]
Cory Klippsten appointed to Millennium Blockchain Board of Advisors
02/02/2018
Advisor to Top Blockchain Projects, Tech Startups and VCs, formerly of Google, McKinsey and Microsoft LAS VEGAS, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Millennium Blockchain Inc. (OTC:THCT) (the “Company”) is pleased to [...]
Immunovaccine to Present at 2018 BIO CEO & Investor Conference
02/02/2018
HALIFAX, Nova Scotia, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced it will participate in this year’s BIO CEO and Investor [...]
Trevena Promotes Carrie Bourdow to Executive Vice President and Chief Operating Officer
02/02/2018
CHESTERBROOK, Pa., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN ) today announced the promotion of Carrie L. Bourdow from Senior Vice President and Chief Commercial Officer to Executive Vice President [...]
Recro Pharma Announces Key Sales Team Additions
02/02/2018
MALVERN, Pa., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH ), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today [...]
miRagen Therapeutics Presents New Data from Phase 1 Clinical Trial of MRG-106 in Mycosis Fungoides at the T-Cell Lymphoma Forum
02/02/2018
90% of evaluable patients show clinical improvement in the ongoing Phase 1 clinical trial of MRG-106. 80% of patients treated with 300 mg IV infusion, the anticipated Phase 2 clinical trial dose, demonstrated an [...]
Aixplorer® and Aixplorer® Ultimate Ultrasound Diagnostic Systems Receive 510(k) Clearance for Clinical Management of Liver Disease
02/02/2018
AIX-EN-PROVENCE, France, Feb. 02, 2018 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext:SSI) (FR0010526814), a company specializing in ultrasound medical imaging, announced today that the Aixplorer® and Aixplorer® [...]
TG Therapeutics, Inc. Announces Updated Results from the Ongoing Phase 2 Study of Ublituximab (TG-1101) in Patients with Multiple Sclerosis at the Third Annual ACTRIMS Forum 2018
02/02/2018
100% reduction of T1 Gd-enhancing lesions at week 24 (n=38) 99% median B-cell depletion was observed at week 4 and maintained at week 24 (n=40) TG-1101 was well tolerated across all patients including those receiving 1 [...]
Outcome of Infant Bacterial Therapeutics' rights issue
02/02/2018
Not for release, publication or distribution, directly or indirectly, in or into Australia, Hong Kong, Japan, Canada, Singapore, the United States or in any other jurisdiction where such distribution of this press [...]
Aquinox to Present at LEERINK Partners 7th Annual Global Healthcare Conference
02/02/2018
VANCOUVER, British Columbia, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“ Aquinox ”) (NASDAQ: AQXP ), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to [...]
Athersys Enters Into New $100 Million Equity Facility with Aspire Capital
02/02/2018
Provides access to capital to support ongoing business and development objectives CLEVELAND, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX ) and Aspire Capital Fund, LLC (“Aspire Capital”) announced [...]
OraSure Technologies Appoints Aradhana Sarin, M.D. to Board of Directors
02/02/2018
BETHLEHEM, Pa., Feb. 02, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ), a leader in point of care diagnostic tests and specimen collection devices, today announced the appointment of Dr. Aradhana [...]
OpGen Announces Pricing of $12 Million Upsized Public Offering
02/02/2018
GAITHERSBURG, Md., Feb. 02, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN ) announces the pricing of a public offering of an aggregate of 3,692,307 units. Each unit is comprised of one share of common stock (or [...]
Announcement by Irina Maligina and Nika Saveljeva, Daughters of Late Valerijs Maligins
02/02/2018
Olaine, 2018-02-02 08:57 CET (GLOBE NEWSWIRE) -- In relation to the sudden passing away of our father Valerijs Maligins and his will to share his inheritance equally among all three of his daughters, we would like to [...]
Solon Eiendom ASA : Primary insider notification
02/02/2018
(Oslo, Norway, February 01, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Skøien AS) has today bought 45.000 shares in Solon Eiendom ASA at a price of NOK 21.8681. Following [...]

Pages